olmesartan has been researched along with Heart Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Eisner, C; Hu, X; Huang, Y; Kopp, JB; Leelahavanichkul, A; Mizel, D; Schnermann, J; Star, RA; Wright, EC; Yan, Q; Yuen, PS; Zhou, H | 1 |
| Hatanaka, K; Hirohata, A; Hirohata, S; Hirose, E; Ito, H; Kobayashi, Y; Komatsubara, I; Kusachi, S; Miyoshi, T; Ohara, M; Ohe, T; Ohkawa, K; Sano, F; Takafuji, H; Toyama, Y; Yamamoto, K; Yamawaki, H | 1 |
| Aizawa, T; Iinuma, H; Iwasaki, YK; Kato, T; Sagara, K; Sawada, H; Sekiguchi, A; Tsuneda, T; Yamashita, T | 1 |
1 trial(s) available for olmesartan and Heart Diseases
| Article | Year |
|---|---|
Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angiotensin II Type 1 Receptor Blockers; Cerebrovascular Disorders; Chi-Square Distribution; Coronary Artery Disease; Disease Progression; Disease-Free Survival; Female; Heart Diseases; Humans; Imidazoles; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2012 |
2 other study(ies) available for olmesartan and Heart Diseases
| Article | Year |
|---|---|
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Desoxycorticosterone; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Glomerulonephritis; Heart Diseases; Hydralazine; Hypertension; Imidazoles; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Kidney Diseases; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nephrectomy; Sodium Chloride, Dietary; Species Specificity; Telemetry; Tetrazoles; Time Factors; X-Ray Microtomography | 2010 |
Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapidly paced atria in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Fibrillation; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Down-Regulation; Endocardium; Heart Atria; Heart Diseases; Imidazoles; Immunohistochemistry; Lipoproteins; Myocardium; Nitric Oxide Synthase Type III; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Thrombomodulin; Up-Regulation | 2007 |